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Calcitriol synthesis is decreased in spontaneously
hypertensive rats
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Ann Arbor, Michigan, USA
Calcitriol synthesis is decreased in spontaneously hypertensive rats. To
investigate the mechanisms of abnormal calcium metabolism, such as
hypocalcemia, decreased intestinal calcium absorption and hypercal-
ciuria in spontaneously hypertensive rats (SHR), we have measured the
plasma concentration of calcitriol and its synthesis in 5-, 8-, 12-, 16-,
and 20-week-old normotensive Wistar Kyoto rats (WKY) and SI-IR.
Metabolic clearance rate (MCR) and production rate (PR) of calcitriol
were measured by the constant isotope infusion method. Plasma
concentration of calcitriol and PR of calcitriol were decreased in SHR
after 12 weeks of age. MCR of calcitriol, however, was not different
between WKY and SHR in any age group. Thercfore, the decreased
synthesis of calcitriol accounts for the lower plasma level of calcitriol in
SHR afer 12 weeks of age. Metabolic acidosis or decreased renal
function could not account for the decreased synthesis of calcitriol,
since the blood pH and pCO2 and creatinine clearance were similar
between WKY and SHR at times when the calcitriol synthesis was
reduced in SHR. Plasma concentration of ionized calcium was also
lower in SHR after 12 weeks of age. Plasma concentration of calcitonin
was significantly higher in 16-week-old SHR (41.6 1.5 pg/mi) than in
age-matched WKY (30.5 1.7, P <0.001). The values, however, were
not different between 8- and 12-week-old WKY and SHR. We believe
that the decreased synthesis of calcitriol could be the pathogenetic
factor for the development of abnormal calcium metabolism in SHR.
Age of animals should be considered when studying the calcium
metabolism in SHR.
Abnormalities of calcium metabolism, such as hypocalcemia
[1—3], decreased intestinal absorption of calcium [4—6] and
hypercalciuria [1] has been described in spontaneously hyper-
tensive rats (SHR) as compared to normotensive Wistar Kyoto
rats (WKY). Associated with these metabolic alterations are
elevated plasma levels of parathyroid hormone [1]. The findings
of abnormal calcium metabolism, however, are not consistently
reported by investigators. For instance, hypocalcemia is not
uniformly observed in all age groups of SHR [2, 7, 8], while
hypercalciuria only occurs after 17 weeks of age [1]. Elevations
of parathyroid hormone have been reported in SHR after 18
weeks of age [1], and parathyroid gland is enlarged in 11-week-
old SHR [9]. The levels, however, are not different in 8 to
12-week-old WKY and SHR [11]. The reasons for the inconsis-
tent findings of abnormal calcium metabolism and hyperpara-
thyroidism could be due to differences in the age of the animals
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studied [12]. We and Kawashima [13, 14] have previously
described abnormal calcitriol metabolism in SHR. In order to
determine whether abnormal calcitriol metabolism is responsi-
ble for the development of abnormal calcium metabolism ob-
served in SHR, we have measured calcitriol synthesis in
different age groups of WKY and SHR. We found that calcitriol
synthesis was decreased in SHR after twelve weeks of age
when compared to WKY.
Methods
Metabolic production of calcitriol was measured in 5-, 8-, 12-,
16-, and 20-week-old male WKY and SHR obtained from
Charles River Breeding Co., Boston, Massachuserts, USA. All
animals were fed Purina rat chow containing 1% calcium, 0.8%
phosphorus, and 4.5 IU vitamin D per gram of diet for one week
in our laboratory prior to the study. On the day of experiments,
animals were weighed and anesthetized with ether for surgery.
Both femoral artery and vein were cannulated with polyethyl-
ene tubing for blood sampling and infusion purposes. The
bladder was also catheterized with polyethylene tubing for
urine collection. After surgery, all animals were placed in
individual restraining cages and allowed to awake from anes-
thesia. Mean arterial pressure (MAP) was measured through the
femoral arterial catheter using a Hewlett-Packard model 78205
C manometer.
Metabolic clearance rate (MCR) of calcitriol was determined
by the constant isotope infusion technique [11]. Radioactive
calcitriol (la,25(26,27-3H)(OH)2D3, specific activity 160 Ci!
mmole and 96% of purity; New England Nuclear, Boston,
Massachusetts, USA) in ethanol was mixed with 0.5 ml of rat
plasma and diluted with a sufficient volume of normal saline to
infuse intravenously into rats at a rate of 0.005 ml/min!l00 g.
Approximately 0.01 uCi!hr radioactive calcitriol was infused
into each animal for 20 hours. Animals were fasted during the
infusion. The total amount of radiolabelled calcitriol infused
into each animal was approximately 3% of the estimated daily
production of calcitriol [11]. Arterial blood, 0.5 ml, was with-
drawn at 18, 19, and 20 hours after the isotope infusion. The
blood was centrifuged immediately, and plasma was separated
from RBC and stored at —20°C until radioactive calcitriol was
determined. The RBC were mixed with saline equivalent to
plasma volume taken from the rat and returned to the animal.
Plasma levels of radioactive calcitriol were measured as
previously described [11]. Two hundred microliters of thawed
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Table 1. Body weight, mean arterial pressure, creatinine clearance,
and blood gases of WKY and SHR
Age
Body wt
g
MAP
mmHg pH
pCO2
mmHg
5 Weeks WKY
N= 8
SHR
N= 8
72 2.5
85 4.6
114 1.9
121 1.1
—
—
—
—
P <0.02 <0.02
8 Weeks WKY
N= 7
SHR
N= 7
193 2.3
192 1.8
116 1.9
153 1.5
7.40 .01
7.40 .01
32.1 1.9
32.2 1.6
P NS <0.001 NS NS
12 Weeks WKY
N= 7
SHR
N= 7
251 4.6
251 10.2
119 2.3
162 2.5
7.43 .01
7.42 .01
38.2 1.8
40.0 1.7
P NS <0.001 NS NS
16 Weeks WKY
N= 7
SHR
N= 7
275 4.9
275 10.8
121 2.7
160 2.1
7.42 .01
7.42 .01
34.6 2.1
36.1 1.6
P NS <0.001
20 Weeks WKY
N= 8
SHR
N= 8
343 6.4
370 6.9
122 2.2
171 2.8
7.42 .01
7.42 .01
38.9 0.8
37.4 1.5
P <0.02 <0.001 NS NS
Abbreviation: MAP, mean arterial pressure.
plasma were brought up to a volume of I ml with normal saline.
Cold calcitriol (500 ng in 50 d absolute ethanol) was added into
the plasma to monitor recovery. Plasma protein was precip-
itated with 1 ml of acetonitrile. The supernatant was combined
with 0.5 ml K2HPO4 (0.4 M, pH 10.6) and applied to a LC-18
Supeclean minicolumn (Supelco Inc., Bellefonte, Pennsylvania,
USA). The column was eluted with 5 ml of double distilled
water, 3 ml of 70% methanol, and 6 ml of acetonitrile. The latter
fraction, containing the vitamin D metabolites, was dried under
nitrogen. The residue was dissolved in 500 d of the HPLC
solvent containing 88% hexane, 10% isopropanol, and 2%
methanol. The solution was injected into a high performance
liquid chromatography solvent delivery system (SP 8710, Spec-
tra Physics, San Jose, California, USA) equipped with a 5 s
silica analytical column (Altech 605 SI, Deerfield, Illinois,
USA). Solvent flow rate was 2 mI/mm, and 1 ml fractions were
collected concurrent with the appearance of the cold calcitriol
peak on a 254 nm optical detector (8300, Spectra Physics).
Recovery of cold calcitriol averaged 75%.
Metabolic clearance rate (MCR) and production rate (PR) of
calcitriol were calculated as follows:
MCR =
Infusion rate of 3H-calcitriol
Mean steady-state plasma concentration of 3H-calcitriol
PR = MCR x endogenous plasma concentration of calcitriol
PR = MCR x endogenous plasma concentration of calcitriol
At the end of isotopic infusion, heparinized arterial blood was
obtained anaerobically in conscious animals. Plasma ionized
Fig. 1. Plasma concentrations of calcitriol in different age groups of
WKY) and SHR (a).
calcium, pH and pCO2 were measured immediately. In addi-
tion, plasma concentration of calcitriol, calcitonin, calcium,
phosphorus and creatinine were also determined. Twenty-hour
urine was collected during the isotope infusion for determina-
tions of calcium and creatinine.
Analytical methods
Calcium was measured by atomic absorption spectrophotom-
etry (Model 306, Perkin Elmer, Norwalk, Connecticut, USA).
Ionized calcium concentration was measured by a NOVA
Model 6 calcium electrode (NOVA Biomedical, Newton, Mas-
sachusetts, USA). Blood pCO2 and pH were measured using an
IL 713 pH/blood gas analyzer (Instrumentation Lab Inc., Lex-
ington, Massachusetts, USA). Creatinine and phosphorus were
determined as previously described [151. Plasma concentration
of calcitriol was measured using radioreceptor assay kit (Immu-
no Nuclear Corp.., Stiliwater, Minnesota, USA) according to
the method of Reinhardt et al [161. Calcitonin was measured
using calcitonin-2 radioimmunoassay kit (Immuno Nuclear
Corp.). The detectable limit was 0.8 pg per tube.
Results
Table 1 shows the results of body weight, MAP, blood pH,
and pCO2. Five- and 20-week-old SHR were heavier than their
age-matched WKY. MAP was significantly higher, as expected,
in all age groups of SHR. Blood pH and pCO2 were not different
between WHY and SHR.
Plasma concentrations of total calcium, ionized calcium,
phosphorus, calcitonin, and creatinine clearance as well as
urinary calcium excretion are summarized in Table 2. Although
total plasma concentrations of calcium were not different be-
tween WKY and SHR, plasma ionized calcium concentrations
were significantly lower in SHR after 12 weeks of age. Plasma
,hosphorus was slightly but significantly lower in 5-week-old
SHR. Creatinine clearance and urinary calcium excretion mea-
sured during the isotope infusion were similar in both groups of
animals. Plasma concentration of calcitonin was measured in 8-,
12-, and 16-week-old WKY and SHR. The concentration was
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Table 2. Plasma concentrations of calcium, ionized calcium, phosphorus, and urinary excretion of calcium in WKY and SHR
++
Ca PPAge
weeks mg/dl mi/mm/lOU g
UcaV
/ig/min
Calcitonin
pg/mi
5 WKY N = 8 10.2 .09 10.5 .2 0.36 .02 0.26 .03
SHRN= 7 10.0 .11 9.9± .2 0.40 .02 0.17 .03
P NS <0.05 NS NS
8 WKY N = 7 10.3 .14 4.60 .04 8.9 .3 0.42 .02 0.26 .03
SHR N = 7 10.2 .13 4.54 .04 8.2 .4 0.42 .03 0.26 .02
P NS NS NS NS NS
12 WKY N = 7 9.7 .12 4.49 .03 7.1 .2 0.50 .02 0.34 .05
SHR N = 7 9.5 .06 4.23 .06 6.9 .2 0.53 .03 0.38 .08
P NS <0.001 NS NS NS
16 WKY N = 7 9.4 .09 4.66 .04 6.7 .2 0.48 .05 0.23 .04
SHR N = 7 9.2 .13 4.33 .05 6.7 .2 0.55 .03 0.28 .02
P NS <0.001 NS NS NS
20 WKY N = 8 9.5 .08 4.73 .02 7.1 .3 0.47 .05 1.02 .35
SHRN = 8 9.3 .10 4.44 .03 6.9± .3 0.41 .04 0.64 .15
P NS <0.001 NS NS NS
28.9 1.5
31.9 2.0
NS
30.3 1.7
35.2 2.4
NS
30.5 1.7
41.6 1.5
<0.001
E
C)
Time, hour
Abbreviations are: PCa and PCa total plasma calcium and plasma ionized calcium; P, plasma phosphorus; CCr, creatinine clearance; UcaV,
urinary calcium excretion.
5 Week 8 Week 12 Week 16 Week 20 Week
0.6 0.6 0.6 0.6 0.6
0.5 0.5 0.5 0.5 0.5
0.4 0.4 0.4 0.4 0.4
0.3 0.3 0.3 0.3 0.3
0.2 0.2 0.2 0.2
0.1 0.1 0.1 0.1
0.1______0.0 . 0.0 , 0.0 0.01 0.0 Fig. 2. Mean metabolic clearance rates of calcitriol
18 19 20 18 19 20 18 19 20 18 19 20 18 19 20 (MCR) at 18, 19, 20 hours after the radioactive
calcitriol infusion in different age groups of WKY
and SHR.
Fig. 3. Average metabolic clearance rates of caicitriol in different age
grous of WKY (U) and SHR (121).
accounted for the lower concentrations of calcitriol in SHR,
since MCR of calcitriol were not different between WKY and
SHR.
significantly higher in 16-week-old SHR, but it was not different
between 8- and 12-week-old WKY and SHR.
Plasma concentrations of calcitriol were not different be-
tween WKY and SHR before 8 weeks of age. The levels,
however, were significantly lower in SHR after 12 weeks of age
(Fig. 1). The mean MCR of calcitriol of the different age groups
of WKY and SHR at 18, 19, and 20 hours after the infusion of
isotope are depicted in Figure 2. The MCR of each group of
animals achieved a steady state, as the MCR measured at the
above time intervals were not different within each group of
animals (paired t-test). Coefficient of variation for the plasma
tracer measurements averaged 4.4% (ranges from 0.4 to 8.7%).
The average MCR of 18, 19, and 20 hours of each group of
animals are presented in Figure 3. The MCR were not different
between WKY and SHR at any age. The MCR of calcitriol in
5-week-old animals, on the other hand, were significantly higher
than those of the older age groups of animals. The production
rates of calcitriol of different age groups of WKY and SHR are
shown in Figure 4. In general, the daily production of calcitriol
tended to decrease as both WKY and SHR grew older. The PR
of calcitriol were not different between WKY and SHR at 5 and
8 weeks of age; however, PR became significantly lower in SHR
after 12 weeks of age. Therefore, decreased PR of calcitriol
160 —
50 —
40-t -
30
0
20a
C0U
Ago, weeks
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Fig. 4. Production rates of calcitriol in different age groups of WKY(U)
and SHR (a).
Discussion
Reports from several laboratories have indicated that calci-
triol metabolism is altered in SHR [13, 14, 17]. SHR have
subnormal response of plasma calcitriol to PTH [13, 14] and
cAMP infusion [13] and dietary phosphorus restriction [13, 17]
in comparison to WKY. We have also demonstrated that
calcitriol synthesis following parathyroid hormone infusion is
significantly lower in SHR [111. However, basal plasma con-
centration of calcitriol is reported to be similar between 4- [14]
and 12-week-old [4, 141 WKY and SHR. Others have reported
lower values in 12- and 14-week-old SHR [5, 13, 17]. In one
study [8], the level of calcitriol is significantly higher in 3- to
4-week-old SHR. Differences in the dietary contents of calcium,
phosphorus and vitamin D as well as sampling bloods in fasting
and non-fasting states might account for the inconsistent find-
ings. Kawashima [14] has recently demonstrated that in vitro
basal calcitriol production rate is significantly greater in SHR at
4 and 12 weeks of age. Since plasma levels of calcitriol are not
different from those of WKY despite the increased calcitriol
production rates, the author suggested that the degradation of
calcitriol must be increased in SHR [14]. The present study has
demonstrated that calcitriol synthesis is not different between
WKY and SHR before 8 weeks of age. The production rate,
however, is decreased in SHR after 12 weeks of age. Decreased
production rather than increased degradation accounts for the
lower plasma concentrations of calcitriol in older SHR. The
reason for the discrepancy between the decreased in vivo
synthesis and the reported increased in vitro synthesis of
calcitriol in SHR is not clear.
Conflicting results of plasma ionized calcium have been
previously reported in SHR [2, 7, 8, 10]. Concentration of
ionized calcium was measured in anesthetized animals. Blood
pH and pCO2 were not measured to exclude the influence of
hypo- or hyperventilation in some of these studies. We have
found that the development of lower ionized calcium concen-
trations is concomitantly associated with the decreased synthe-
sis of calcitriol in SHR. Plasma concentration of ionized cal-
cium is not different between 8-week-old WKY and SHR.
However, the values are significantly lower in SHR after 12
weeks of age. Calcium concentration is regulated by intestinal
absorption of calcium, renal handling of calcium, and mobiliza-
tion of bone calcium. These processes are integrated by para-
thyroid hormone, vitamin D, and calcitonin. Hypocalcemia
conceivably could result from changes in any of these processes
or combinations thereof. Several studies have indicated that
intestinal absorption of calcium is decreased in SHR in com-
parison to WKY [4, 5], though the issue remains controversial
[7]. The impaired calcitriol metabolism could very well affect
intestinal absorption of calcium in older SHR. Renal wasting of
calcium could also lead to hypocalcemia. The fasting urinary
excretion of calcium is not lower in SHR, even though the
ionized calcium is lower, suggesting that renal handling of
calcium is inappropriate in SHR. Recent studies have demon-
strated that physiological concentrations of calcitriol play an
important role in renal tubular reabsorption of calcium [18, 19].
The synthesis of calcitriol progressively declines in SHR with
age. The decreased plasma concentration of calcitriol could
lead to the development of hypercalciuria. Finally, skeletal
response to parathyroid hormone may alter the plasma concen-
tration of calcium. We have previously shown that the calcemic
response to pharmacological doses of parathyroid hormone is
identical between fasted WKY and SHR [20]. Thus skeletal
resistance to parathyroid hormone could not account for the
hypocalcemia in SHR.
Bindels et al [10] and others [21, 221 have recently reported
that plasma concentration of calcitonin is higher in SHR. We
have confirmed that plasma level of calcitonin is higher in
16-week-old SHR, but not in 8- and 12-week-old SHR. It is not
clear why we were unable to detect the elevated concentrations
in younger SHR. Although acute administration of calcitonin
results in decreasing plasma concentrations of calcium, chronic
infusion of calcitonin tends to increase plasma calcium and
normalize calcium concentration in thyroparathyroidectomized
rats [23]. The hypocalcemic effect is presumably opposed by
increased plasma calcitriol levels stimulated by calcitonin [23].
Failure of calcitonin to stimulate calcitriol synthesis in SHR as
evidenced by the depressed calcitriol level, therefore, leaves
the hypocalcemic effect of calcitonin unopposed. The elevated
calcitonin could further contribute to the hypocalcemia in SHR
after 16 weeks of age.
Plasma concentrations of parathyroid hormone are not dif-
ferent between 8- and 12-week-old WKY and SHR [10, 11]. The
levels, however, are reported to be significantly higher in SHR
after 18 weeks of age [I]. Since calcitriol may directly or
indirectly modulate plasma concentrations of parathyroid hor-
mone [24, 25], the lower plasma levels of calcitriol could be a
pathogenetic factor of the secondary hyperparathyroidism in
SHR.
In summary, the present study has demonstrated that plasma
concentration of calcitriol and its synthesis are decreased in
SHR as they grow older. The decreased calcitriol synthesis
could be responsible for the development of abnormal calcium
metabolism in SHR. Age factor should be taken into consider-
ation when studying calcium metabolism in SHR.
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